Liping Dou
Clinical trials sponsored by Liping Dou, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New CAR-T therapy aims to keep leukemia in remission Results expected Dec 2026 (estimated)
- New CAR-T therapy aims to keep High-Risk leukemia in remission Results expected Dec 2026 (estimated)
- Engineered immune cells aim to deepen remission in lymphoma patients Results expected Jan 2027 (estimated)
- Can engineered immune cells lock in remission for aggressive lymphoma? Results expected Apr 2027 (estimated)